Sectors & IndustriesHealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology
F
Biotech is Zen Rated F and is the 133rd ranked industry out of 145 stock market industries
Learn how the Zen Ratings work
Ticker
Company
Price
1d %
1w %
1m %
3m %
6m %
1y %
3y %
5y %
10y %
52-week High
52-week Low
% off 52-week High
% off 52-week Low
Beta
Volume
Vol 1d %
MDXG
MIMEDX GROUP INC
$7.653.38%13.17%9.60%6.40%11.19%11.68%158.45%25.41%-2.05%$10.14$5.7924.56%32.12%1.252,801,000-18.76%
INCY
INCYTE CORP
$93.480.96%2.41%10.22%24.82%49.19%26.12%25.75%10.71%-22.52%$95.10$53.561.70%74.53%0.552,503,0004.03%
TBPH
THERAVANCE BIOPHARMA INC
$14.662.52%2.66%0.41%31.36%50.05%77.91%47.04%-21.14%-8.83%$15.15$7.903.23%85.57%0.63393,00062.40%
AUPH
AURINIA PHARMACEUTICALS INC
$13.178.66%10.77%19.19%42.46%59.83%82.66%61.99%-15.03%336.09%$13.54$6.552.73%101.07%1.122,658,000124.49%
BCRX
BIOCRYST PHARMACEUTICALS INC
$7.320.97%1.67%-3.56%-10.07%-17.29%-8.61%-45.17%90.38%-25.76%$11.31$6.0035.28%22.00%1.205,729,00017.37%
RIGL
RIGEL PHARMACEUTICALS INC
$31.58-0.13%5.37%11.47%49.95%61.45%131.69%333.43%26.32%12.38%$43.72$13.9127.76%127.03%1.32473,000-5.21%
ONC
BEONE MEDICINES LTD
$310.480.73%-0.11%-8.87%3.10%19.50%53.22%83.84%3.84%N/A$355.30$170.9912.61%81.58%0.98142,000-22.40%
HALO
HALOZYME THERAPEUTICS INC
$65.190.87%-1.45%-11.11%8.70%6.14%28.91%36.35%129.54%290.83%$79.50$42.0118.00%55.18%0.841,415,000-21.17%
ARQT
ARCUTIS BIOTHERAPEUTICS INC
$25.311.57%25.86%34.27%73.59%69.75%204.57%43.16%35.20%N/A$27.08$8.296.53%205.31%1.232,300,000-24.86%
PBYI
PUMA BIOTECHNOLOGY INC
$5.10-6.59%-2.49%-3.95%63.99%60.38%78.95%133.94%-34.45%-94.46%$6.07$2.3215.98%119.83%1.00432,000-21.02%
AKBA
AKEBIA THERAPEUTICS INC
$2.215.24%-27.06%-19.05%-40.03%-8.30%33.13%766.67%-4.33%-77.74%$4.08$1.5245.82%45.39%1.496,112,000-33.29%
INVA
INNOVIVA INC
$18.201.39%2.77%-0.27%0.17%-2.62%-6.95%34.22%77.56%104.49%$22.00$16.5217.27%10.17%0.43668,000-9.73%
MIRM
MIRUM PHARMACEUTICALS INC
$72.650.62%3.76%-0.90%40.58%67.20%88.90%222.17%341.11%N/A$78.54$36.887.50%96.99%0.71390,000-17.55%
XERS
XERIS BIOPHARMA HOLDINGS INC
$9.70-0.10%5.32%19.16%90.57%112.25%201.24%506.25%118.47%N/A$10.03$2.823.24%243.97%1.241,924,00019.50%
ALNY
ALNYLAM PHARMACEUTICALS INC
$456.041.44%-1.59%0.01%16.27%73.24%71.06%120.03%265.09%390.00%$495.55$205.877.97%121.52%0.931,818,000-20.92%
ZYME
ZYMEWORKS INC
$19.09-0.18%7.58%11.74%51.95%46.69%39.31%156.86%-51.87%N/A$19.98$9.034.48%111.35%0.96345,000-59.32%
GMAB
GENMAB A
$28.61-0.21%-4.28%-6.72%32.03%35.27%28.18%-25.71%-15.78%183.66%$33.65$17.2414.98%66.00%0.711,574,000-43.91%
TVTX
TRAVERE THERAPEUTICS INC
$35.1618.58%25.30%47.11%127.57%68.96%100.91%62.18%74.49%67.43%$35.34$12.910.51%172.35%1.126,251,000240.28%
CRMD
CORMEDIX INC
$11.13-4.22%-0.36%-4.30%-4.63%21.11%10.69%262.54%122.60%-18.16%$17.43$5.6036.14%98.75%1.052,177,000-2.16%
NAGE
NIAGEN BIOSCIENCE INC
$7.546.05%-0.40%-19.19%-19.36%-3.95%116.05%396.05%69.82%74.54%$14.69$5.1648.67%46.12%1.341,034,00060.06%
VRTX
VERTEX PHARMACEUTICALS INC
$425.571.35%0.99%8.66%-6.85%-16.47%-10.59%36.40%105.17%235.25%$519.88$362.5018.14%17.40%0.571,499,00021.47%
ARGX
ARGENX SE
$818.50-0.23%0.14%10.97%22.10%26.87%39.60%110.99%228.07%N/A$855.46$510.064.32%60.47%0.67403,000-56.48%
XOMA
XOMA ROYALTY CORP
$32.98-0.72%-6.23%-14.43%32.56%37.19%9.21%99.15%37.25%10.67%$39.92$18.3517.38%79.71%0.8735,700-16.00%
FOLD
AMICUS THERAPEUTICS INC
$9.031.46%4.15%14.59%50.75%17.58%-20.93%-9.70%-49.10%3.56%$12.65$5.5128.62%63.88%1.004,891,000-0.29%
LGND
LIGAND PHARMACEUTICALS INC
$191.312.27%2.32%8.00%45.39%74.14%80.99%118.27%130.77%101.23%$194.44$93.581.61%104.43%1.14383,000283.00%
ABUS
ARBUTUS BIOPHARMA CORP
$4.73-2.27%8.49%4.19%44.21%33.24%23.02%102.14%71.38%-18.87%$5.10$2.717.25%74.86%0.97809,000-56.08%
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL PLC
$37.01-0.75%-4.93%-4.69%22.31%37.23%63.83%224.08%140.01%N/A$42.05$17.8211.99%107.69%0.85482,000-5.12%
ASND
ASCENDIS PHARMA A
$201.60-1.04%-0.20%1.40%16.20%18.28%64.14%75.30%24.07%1,005.26%$216.45$118.036.86%70.80%0.74314,00017.16%
HRMY
HARMONY BIOSCIENCES HOLDINGS INC
$28.57-1.14%-5.55%3.66%-18.79%-3.05%-11.08%-45.06%-25.91%N/A$40.93$25.5230.20%11.95%0.85713,000-11.76%
VCYT
VERACYTE INC
$36.082.12%-1.77%5.10%53.47%18.30%6.94%79.41%3.09%489.54%$47.32$22.6123.75%59.58%1.95624,00019.54%
LXRX
LEXICON PHARMACEUTICALS INC
$1.382.99%-2.82%2.22%28.97%88.78%-29.23%-35.81%31.43%-86.47%$1.66$0.2816.87%385.92%1.431,111,000-7.42%
FBIO
FORTRESS BIOTECH INC
$2.56-0.39%1.99%-30.81%38.38%44.63%34.74%-79.44%-92.31%-94.07%$4.20$1.3339.05%93.21%1.18291,000-27.25%
REGN
REGENERON PHARMACEUTICALS INC
$651.80-0.34%12.78%15.92%19.50%8.86%-22.24%-12.95%18.82%12.57%$852.01$476.4923.50%36.79%0.61798,000-28.75%
DOMH
DOMINARI HOLDINGS INC
$5.112.82%-12.80%-27.93%12.31%11.33%200.59%-16.23%-38.52%-98.79%$13.58$0.8362.37%518.64%1.29150,000-27.18%
FENC
FENNEC PHARMACEUTICALS INC
$8.20-1.56%-8.79%-12.39%0.24%35.76%88.07%-6.82%11.87%507.41%$9.92$3.9617.34%107.07%0.6679,00036.21%
EXEL
EXELIXIS INC
$38.67-0.69%-0.13%-6.37%6.76%-1.23%16.48%133.23%87.63%528.78%$49.62$31.9022.07%21.22%0.612,112,000-4.43%
CPRX
CATALYST PHARMACEUTICALS INC
$21.271.43%1.48%7.97%-0.28%-12.43%-2.43%53.35%616.16%536.83%$26.58$19.0519.98%11.65%1.05980,000-0.20%
RPRX
ROYALTY PHARMA PLC
$37.541.62%0.75%6.41%2.01%14.38%39.04%-11.29%-0.11%N/A$38.00$24.051.21%56.09%0.503,773,000106.85%
VALN
VALNEVA SE
$9.271.53%-2.93%-24.02%26.12%46.10%64.07%-30.29%N/AN/A$12.25$3.6224.33%156.08%1.079,10026.39%
ZVRA
ZEVRA THERAPEUTICS INC
$10.180.39%-4.05%7.05%-8.37%38.88%24.91%81.79%3.46%-96.28%$13.16$6.1922.64%64.46%0.90926,000-9.30%
INBX
INHIBRX BIOSCIENCES INC
$81.664.01%42.54%142.46%272.54%562.29%409.42%N/AN/AN/A$83.95$10.812.73%655.76%1.17481,000-49.21%
FTRE
FORTREA HOLDINGS INC
$10.464.29%-7.43%24.23%82.23%67.90%-37.81%N/AN/AN/A$25.28$3.9758.62%163.48%1.621,125,000-20.94%
SLGL
SOL-GEL TECHNOLOGIES LTD
$34.50-6.76%-11.54%18.35%173.81%353.95%604.08%-30.37%-57.41%N/A$52.26$4.0133.98%761.21%0.5714,900156.90%
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
$17.362.66%0.81%16.04%69.53%135.87%258.68%123.14%-62.13%N/A$17.89$4.272.94%306.56%2.041,911,00026.06%
ATRA
ATARA BIOTHERAPEUTICS INC
$14.855.73%2.48%3.63%28.91%85.86%66.67%-87.25%-95.31%-97.95%$18.71$5.0120.61%196.70%1.9351,40012.47%
CORT
CORCEPT THERAPEUTICS INC
$73.471.67%1.31%-11.60%9.38%2.21%50.03%156.89%322.00%1,714.07%$117.33$47.6337.38%54.25%0.89687,00018.86%
FHTX
FOGHORN THERAPEUTICS INC
$4.412.32%8.35%-9.82%-16.00%5.00%-42.13%-49.54%-72.35%N/A$9.70$2.9554.54%49.75%1.50152,00027.73%
SPRO
SPERO THERAPEUTICS INC
$2.432.97%9.95%29.26%4.74%269.30%97.56%23.98%-81.45%N/A$3.22$0.5124.53%381.19%0.76493,00048.05%
MESO
MESOBLAST LTD
$16.661.40%-0.89%3.41%9.17%46.14%98.81%186.25%-23.23%N/A$22.00$8.3424.27%99.76%1.25146,00073.81%
OVID
OVID THERAPEUTICS INC
$1.391.46%-14.72%6.92%178.00%325.08%23.01%-14.72%-71.86%N/A$2.01$0.2430.85%474.38%0.881,705,000-22.15%
PLX
PROTALIX BIOTHERAPEUTICS INC
$2.374.87%0.42%6.76%62.33%-22.80%102.56%130.10%-25.24%-76.76%$3.10$1.1623.55%104.31%0.71478,0006.22%
VCEL
VERICEL CORP
$35.061.53%-3.47%11.41%0.34%-7.79%-20.39%30.43%83.75%1,472.20%$63.00$29.2444.35%19.90%1.50635,0006.72%
ORMP
ORAMED PHARMACEUTICALS INC
$2.39-0.42%0.00%-9.47%11.16%3.02%0.42%-66.39%-9.47%-65.21%$3.09$1.8222.65%31.32%1.19113,000-13.08%
BMRN
BIOMARIN PHARMACEUTICAL INC
$53.573.20%-1.67%-1.09%-7.40%-15.89%-18.70%-38.16%-27.04%-54.15%$73.51$51.0027.13%5.04%0.743,251,00021.90%
NTHI
NEONC TECHNOLOGIES HOLDINGS INC
$9.80-3.64%10.61%7.93%100.00%63.33%N/AN/AN/AN/A$25.00$3.2060.80%206.25%-1.1927,500-13.52%
EVAX
EVAXION A
$5.75-0.17%-2.38%52.93%114.55%275.82%-56.93%-95.58%N/AN/A$13.80$1.2058.33%379.17%0.64142,000-53.90%
ARDX
ARDELYX INC
$6.0620.96%20.24%9.98%42.92%10.08%3.24%304.00%16.76%-64.99%$6.78$3.2110.62%88.79%1.1618,733,000208.67%
UTHR
UNITED THERAPEUTICS CORP
$445.43-1.79%6.41%6.25%62.15%46.96%19.11%93.22%232.46%191.02%$479.50$266.987.11%66.84%0.46754,00038.35%
IRD
OPUS GENETICS INC
$2.3016.75%15.58%39.39%107.21%142.11%91.67%-2.13%-68.58%-98.94%$2.30$0.650.13%253.85%0.901,267,000181.56%
XNCR
XENCOR INC
$14.714.10%11.36%25.40%76.80%33.48%-29.99%-47.46%-61.22%24.87%$27.24$6.9246.00%112.57%1.171,211,00025.75%
RLAY
RELAY THERAPEUTICS INC
$7.14-2.72%4.08%36.78%102.84%114.41%26.71%-67.87%-80.01%N/A$7.64$1.786.54%302.25%1.791,454,000-24.31%
ACAD
ACADIA PHARMACEUTICALS INC
$22.70-0.18%3.09%6.37%-4.74%55.48%55.59%41.61%-50.26%-43.50%$26.65$13.4014.82%69.40%0.931,416,00018.99%
JAZZ
JAZZ PHARMACEUTICALS PLC
$137.640.98%-0.64%4.43%20.07%17.68%25.09%-4.28%-6.53%-3.64%$148.06$95.497.04%44.14%0.72524,000-16.43%
KRYS
KRYSTAL BIOTECH INC
$197.514.46%6.11%11.88%28.36%16.26%14.48%158.18%358.90%N/A$207.84$122.804.97%60.84%1.36595,000110.99%
TGTX
TG THERAPEUTICS INC
$34.782.23%4.33%-3.72%-2.03%-23.58%38.79%497.59%33.46%162.09%$46.48$22.9225.17%51.75%1.923,260,000113.63%
IMCR
IMMUNOCORE HOLDINGS PLC
$33.092.80%-0.05%-8.92%0.98%9.93%7.33%-42.09%N/AN/A$39.33$23.1515.87%42.94%0.75280,000104.38%
MDGL
MADRIGAL PHARMACEUTICALS INC
$418.90-2.02%-0.62%-8.67%38.47%25.45%61.53%491.50%229.07%1,660.08%$463.63$265.009.65%58.08%0.78386,00034.03%
SRPT
SAREPTA THERAPEUTICS INC
$24.013.27%5.26%24.60%46.22%-61.52%-80.94%-78.94%-82.51%-6.43%$138.81$10.4282.70%130.53%0.914,510,00031.83%
NBTX
NANOBIOTIX SA
$20.8713.18%8.70%10.48%202.24%515.63%401.68%427.02%N/AN/A$30.35$2.7631.24%656.16%1.01178,00089.36%
PTCT
PTC THERAPEUTICS INC
$68.310.29%2.88%11.31%31.09%37.06%71.12%80.62%24.15%147.14%$69.88$35.952.25%90.01%0.99816,000-4.67%
CYTK
CYTOKINETICS INC
$63.592.15%9.96%15.70%68.94%48.44%24.69%45.65%298.68%515.59%$64.13$29.310.84%116.96%0.992,430,00057.69%
BNTX
BIONTECH SE
$103.91-0.73%-1.66%5.36%-3.34%-0.23%-8.13%-24.51%19.30%N/A$129.27$81.2019.62%27.97%0.92558,0008.14%
BDTX
BLACK DIAMOND THERAPEUTICS INC
$3.871.31%-1.53%2.11%45.49%127.65%41.24%67.53%-87.74%N/A$4.45$1.2013.03%223.85%1.56440,00013.40%
ASMB
ASSEMBLY BIOSCIENCES INC
$31.053.09%6.19%21.29%73.22%172.61%84.71%57.77%-82.46%-72.12%$32.44$7.754.28%300.65%0.9172,00018.03%
SLNO
SOLENO THERAPEUTICS INC
$67.16-3.06%4.64%-0.65%-22.33%-10.29%21.98%6,683.84%157.32%-49.79%$90.32$41.5025.64%61.83%0.471,139,000-4.29%
ENTA
ENANTA PHARMACEUTICALS INC
$10.960.92%4.28%-8.44%44.59%79.97%-2.53%-75.70%-75.27%-65.73%$15.34$4.0928.55%167.97%0.96368,000-45.56%
NAMS
NEWAMSTERDAM PHARMA CO NV
$37.95-1.99%6.24%33.44%74.00%98.38%122.97%278.74%N/AN/A$41.47$14.068.49%169.91%0.42563,000-51.30%
CMMB
CHEMOMAB THERAPEUTICS LTD
$3.062.68%-5.85%16.35%-28.50%-43.33%-46.13%-62.41%-95.95%N/A$9.84$2.4068.90%27.50%1.1552,60087.86%
AXSM
AXSOME THERAPEUTICS INC
$134.991.38%4.20%11.15%33.15%20.22%51.62%198.98%101.90%N/A$139.13$75.562.98%78.65%0.95508,00028.93%
TECH
BIO-TECHNE CORP
$62.572.64%-5.07%12.48%14.32%24.27%-15.16%-15.52%-3.74%176.76%$80.80$46.0122.56%35.99%1.202,108,00051.98%
NVO
NOVO NORDISK A S
$49.46-1.16%-6.61%-10.87%5.08%-25.57%-55.82%-9.11%52.11%84.35%$112.52$45.0556.04%9.79%0.6219,991,000-4.95%
TRAW
TRAWS PHARMA INC
$2.57-2.65%-5.17%38.92%66.88%77.24%-49.01%-85.72%-97.29%-100.00%$19.44$0.9786.78%164.95%0.9686,000-47.56%
TARS
TARSUS PHARMACEUTICALS INC
$68.81-0.22%4.16%15.78%77.25%32.56%54.66%273.56%218.27%N/A$76.81$38.5110.42%78.68%0.89524,00014.91%
OKYO
OKYO PHARMA LTD
$2.745.38%14.64%37.00%1.48%72.87%132.20%20.70%N/AN/A$3.35$0.9018.18%203.77%0.4696,00082.16%
PTHS
PELTHOS THERAPEUTICS INC
$33.00-0.75%4.66%17.86%56.03%189.47%432.00%N/AN/AN/A$54.29$4.5039.22%633.33%1.2012,600-42.20%
ANAB
ANAPTYSBIO INC
$36.580.30%4.31%19.46%49.00%64.63%69.12%26.79%21.93%N/A$38.39$12.214.70%199.59%0.87230,000-28.13%
ARWR
ARROWHEAD PHARMACEUTICALS INC
$42.390.19%11.55%22.91%168.29%205.18%120.44%21.78%-27.19%692.34%$43.69$9.572.98%342.95%1.641,716,000-25.42%
GYRE
GYRE THERAPEUTICS INC
$7.751.31%-5.14%3.89%9.93%-20.59%-45.80%-4.34%-90.67%-99.13%$19.00$6.1159.21%26.84%1.2636,200-21.30%
QURE
UNIQURE NV
$67.69-0.25%10.95%15.97%386.28%358.60%1,083.39%263.53%65.62%260.44%$71.50$5.355.33%1,165.23%1.42891,000-24.75%
ABEO
ABEONA THERAPEUTICS INC
$4.81-5.31%-12.23%-8.90%-24.49%-26.68%-24.96%4.79%-81.32%-95.39%$7.54$3.9336.21%22.30%0.833,973,0001.74%
IMNM
IMMUNOME INC
$16.070.56%2.42%37.23%52.76%82.82%40.10%268.58%46.36%N/A$17.32$5.157.20%212.04%1.48733,00037.52%
TSHA
TAYSHA GENE THERAPIES INC
$4.961.02%4.42%51.68%81.68%155.67%193.49%188.37%-76.38%N/A$5.51$1.059.95%372.38%1.852,683,00013.02%
TCRX
TSCAN THERAPEUTICS INC
$1.944.30%-16.02%6.59%11.49%20.87%-57.27%-28.15%N/AN/A$6.23$1.0268.84%90.20%0.74215,000-82.66%
APLS
APELLIS PHARMACEUTICALS INC
$21.473.57%-23.78%-5.13%-3.89%11.76%-21.24%-64.51%-31.95%N/A$35.72$16.1039.89%33.35%1.006,490,000-34.33%
VRCA
VERRICA PHARMACEUTICALS INC
$3.612.27%-6.23%-16.24%-35.88%-22.23%-74.21%-85.50%-95.18%N/A$15.35$3.4476.48%4.94%0.9032,500-26.14%
ADMA
ADMA BIOLOGICS INC
$15.481.38%1.98%5.59%-17.22%-34.96%-5.09%448.94%644.23%69.18%$25.67$13.5039.70%14.67%1.172,492,0009.20%
STOK
STOKE THERAPEUTICS INC
$30.04-5.24%-6.94%27.83%133.77%207.79%143.04%102.29%-20.63%N/A$38.69$5.3522.36%461.50%1.381,342,000104.26%
PGEN
PRECIGEN INC
$4.142.22%-4.39%25.84%142.11%165.38%425.38%155.56%-0.72%-88.34%$5.23$0.6520.77%535.94%1.696,397,000208.88%
BBIO
BRIDGEBIO PHARMA INC
$62.64-1.15%15.44%20.60%32.52%63.30%167.58%500.58%62.41%N/A$69.48$21.729.84%188.40%1.582,471,000-48.98%
NBY
NOVABAY PHARMACEUTICALS INC
$1.15-2.54%-6.50%-10.16%98.28%97.93%60.61%-99.11%-99.85%-99.98%$4.44$0.4674.10%150.00%0.5752,500-71.31%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Nov 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Mimedx Group (NASDAQ:MDXG)


Mimedx Group (NASDAQ:MDXG) is the #1 top biotech stock out of 624 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Mimedx Group (NASDAQ:MDXG) is: Value: B, Growth: A, Momentum: C, Sentiment: A, Safety: C, Financials: A, and AI: B.

Mimedx Group (NASDAQ:MDXG) has a Due Diligence Score of 48, which is 25 points higher than the biotech industry average of 23.

MDXG passed 15 out of 33 due diligence checks and has strong fundamentals. Mimedx Group has seen its stock return 11.68% over the past year, overperforming other biotech stocks by 32 percentage points.

Mimedx Group has an average 1 year price target of $12.00, an upside of 56.86% from Mimedx Group's current stock price of $7.65.

Mimedx Group stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Mimedx Group, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Incyte (NASDAQ:INCY)


Incyte (NASDAQ:INCY) is the #2 top biotech stock out of 624 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Incyte (NASDAQ:INCY) is: Value: A, Growth: B, Momentum: C, Sentiment: B, Safety: C, Financials: B, and AI: B.

Incyte (NASDAQ:INCY) has a Due Diligence Score of 60, which is 37 points higher than the biotech industry average of 23.

INCY passed 19 out of 33 due diligence checks and has strong fundamentals. Incyte has seen its stock return 26.12% over the past year, overperforming other biotech stocks by 46 percentage points.

Incyte has an average 1 year price target of $88.75, a downside of -5.06% from Incyte's current stock price of $93.48.

Incyte stock has a consensus Buy recommendation according to Wall Street analysts. Of the 12 analysts covering Incyte, 50% have issued a Strong Buy rating, 0% have issued a Buy, 41.67% have issued a hold, while 8.33% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Theravance Biopharma (NASDAQ:TBPH)


Theravance Biopharma (NASDAQ:TBPH) is the #3 top biotech stock out of 624 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Theravance Biopharma (NASDAQ:TBPH) is: Value: B, Growth: A, Momentum: C, Sentiment: C, Safety: D, Financials: A, and AI: C.

Theravance Biopharma (NASDAQ:TBPH) has a Due Diligence Score of 36, which is 13 points higher than the biotech industry average of 23.

TBPH passed 11 out of 33 due diligence checks and has average fundamentals. Theravance Biopharma has seen its stock return 77.91% over the past year, overperforming other biotech stocks by 98 percentage points.

Theravance Biopharma has an average 1 year price target of $25.67, an upside of 75.08% from Theravance Biopharma's current stock price of $14.66.

Theravance Biopharma stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Theravance Biopharma, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 4 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)


Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 10.57%, which is 8 percentage points higher than the biotech industry average of 2.67%.

Dominari Holdings's dividend payout ratio of -13.4% indicates that its high dividend yield might not be sustainable for the long-term.

2. Royalty Pharma (NASDAQ:RPRX)


Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 2.32%, which is the same as the biotech industry average of 2.67%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 37.2% indicates that its dividend yield is sustainable for the long-term.

3. Bio Techne (NASDAQ:TECH)


Bio Techne (NASDAQ:TECH) has an annual dividend yield of 0.51%, which is -2 percentage points lower than the biotech industry average of 2.67%. Bio Techne's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Bio Techne's dividend has not shown consistent growth over the last 10 years.

Bio Techne's dividend payout ratio of 68.1% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 0.7% in the last day, and up 2.96% over the last week. Cabaletta Bio was the among the top gainers in the biotechnology industry, gaining 46.15% yesterday.

Cabaletta Bio shares are trading higher after Cantor Fitzgerald maintained its overweight on the stock and raised Its price target from $15 to $30.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)


Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -11.08% in the past year. It has overperformed other stocks in the biotech industry by 9 percentage points.

2. Puma Biotechnology (NASDAQ:PBYI)


Puma Biotechnology (NASDAQ:PBYI) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has gained 78.95% in the past year. It has overperformed other stocks in the biotech industry by 99 percentage points.

3. Incyte (NASDAQ:INCY)


Incyte (NASDAQ:INCY) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Incyte has a valuation score of 57, which is 43 points higher than the biotech industry average of 14. It passed 4 out of 7 valuation due diligence checks.

Incyte's stock has gained 26.12% in the past year. It has overperformed other stocks in the biotech industry by 46 percentage points.

Are biotech stocks a good buy now?

58.9% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 59.57% over the next year.

2.89% of biotech stocks have a Zen Rating of A (Strong Buy), 4.96% of biotech stocks are rated B (Buy), 44.21% are rated C (Hold), 33.47% are rated D (Sell), and 14.46% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is -9.18x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.